FDA Inspection 943005 — Blue Cross Laboratories, Inc

Blue Cross Laboratories, Inc — FEI 3003425057

The FDA completed an inspection of Blue Cross Laboratories, Inc on Sep 17, 2015 in Santa Clarita, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 17, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Clarita, CA (United States)

Citations

IDCFRDescription
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
121521 CFR 211.67(b)Written procedures not established/followed
176721 CFR 211.137(a)Expiration date lacking
184321 CFR 211.84(d)(2)Component written specification
188321 CFR 211.165(a)Testing and release for distribution
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
900121 CFR 211.22(a)Lack of quality control unit